CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Oct. 29, 2016	Oct. 24, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 4,109	$ 4,430
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	6,063	5,958
Non-cash share-based compensation	797	740
Deferred taxes	(26)	(1,017)
Provision to value inventories at LIFO	0	100
Changes in assets and liabilities:
Merchandise inventories	(1,224)	(1,159)
Patronage dividend receivable	(4,636)	(4,553)
Accounts payable to Wakefern	(3,053)	(68)
Accounts payable and accrued expenses	(118)	7
Accrued wages and benefits	(1,271)	(1,930)
Income taxes payable/receivable	(11,787)	4,112
Other assets and liabilities	(1,171)	(1,205)
Net cash (used in) provided by operating activities	(12,317)	5,415
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(6,795)	(5,328)
Proceeds from Sale of Property, Plant, and Equipment	0	900
Investment in notes receivable from Wakefern	(459)	0
Net cash used in investing activities	(7,254)	(4,428)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	396	0
Excess tax benefit related to share-based compensation	32	0
Principal payments of long-term debt	(216)	(223)
Dividends	(3,162)	(3,164)
Payments for Repurchase of Common Stock	$ 0	(490)
Document Period End Date	Oct. 29, 2016
Net cash used in financing activities	$ (2,950)	(3,877)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(22,521)	(2,890)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	88,379	59,040
CASH AND CASH EQUIVALENTS, END OF PERIOD	65,858	56,150
SUPPLEMENTAL DISCLOSURES OF CASH PAYMENTS MADE FOR:
Interest	1,117	1,128
Income taxes	14,700	100
NONCASH SUPPLEMENTAL DISCLOSURES:
Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)	$ 626	$ 717